Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARHEXA: Heparin and Exercise in Refractory Angina
NCT03350737Completed
- Sponsor
- University Clinical Center of Serbia
- Start
- Feb 2013
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Angina Pectoris (AP) comparing Heparin + Exercise with Placebo + Exercise (2 arms). Primary endpoint: Canadian Cardiovascular Society angina severity class at 2 weeks. Started Feb 2013; status: completed.
02
Drugs
heparin
03
Conditions
Angina Pectoris (AP)
Beyond the preview
Go deeper on NCT03350737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03350737.